Nasser Nasseri, MD on your journey to total well-being with expert care and tailored treatments
Many patients wonder whether they can discontinue GLP-1 therapy after reaching their goals, and the answer depends on your individual metabolic needs and long-term health plan
Featuring HealthWell Multiple Myeloma Medicare Access Fund Grant Recipient Carolyn S., HealthWell President & CEO, Michael Heimall, and HWF Direct Program Director, Michael King Helping Patients Access the Treatments They Need Supporting Patients, Together: Financial Assistance Across the Continuum of Care
Recent animal studies demonstrated that GLP-1 agonists reduce intracranial pressure significantly
Brown GC, Borutaite V
(For more information, see the Interaction with oral medications section.) Note: Cannabis is illegal at a federal level but is legal in many states to varying degrees